12/18/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:02 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/11/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
12/03/2024
4:20 PM | Moleculin Biotech (Filer)
| Form POS AM | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/14/2024
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
4:09 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:00 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:04 PM | Climaco John M (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:05 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:06 PM | Moleculin Biotech (Issuer)
Yan Joy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:27 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:43 PM | Moleculin Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/25/2024
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
08/19/2024
3:10 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
9:06 AM | Moleculin Biotech (Filer)
| Form 424B3 | |
08/16/2024
3:54 PM | Moleculin Biotech (Filer)
| Form 424B4 | |
08/15/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
08/15/2024
10:21 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024
8:57 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024
7:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
8:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:00 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
07/22/2024
4:31 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
07/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
4:01 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
06/25/2024
5:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:01 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:02 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:01 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:01 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:05 PM | Moleculin Biotech (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/16/2024
7:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:38 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:55 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Moleculin Biotech (Filer)
| Form 10-K/A | |
04/25/2024
7:23 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:14 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
8:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
2:03 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:31 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
8:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
4:19 PM | Moleculin Biotech (Filer)
| Form 424B3 | |
02/15/2024
8:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:43 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SC 13G | |
02/12/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
02/02/2024
4:05 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/24/2024
7:50 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:14 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
12/27/2023
6:31 AM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
6:31 AM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
6:32 AM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:00 PM | Moleculin Biotech (Filer)
| Form 424B5 | |
